From: Danshao Shugan Granule therapy for non-alcoholic fatty liver disease
D1 | D2 | D3 | P-value | ||
---|---|---|---|---|---|
Number | 30 | 30 | 30 | ||
TC (mmol/L) | Pre- treatment | 6.52 ± 0.19 | 6.50 ± 0.19 | 6.56 ± 0.17 | 0.439 |
Post treatment | 5.15 ± 0.12 | 4.61 ± 0.09 | 4.77 ± 0.11 | ||
Δ | -1.37 ± 0.94 | -1.89 ± 0.97 | -1.79 ± 0.99 | 0.093 | |
TG (mmol/L) | Pre- treatment | 2.77 ± 0.26 | 2.72 ± 0.22 | 2.76 ± 0.14 | 0.630 |
Post treatment | 1.77 ± 0.07 | 1.45 ± 0.06 | 1.66 ± 0.07 | ||
Δ | -1.00 ± 1.13 | -1.27 ± 1.17 | -1.10 ± 0.69 | 0.586 | |
ALT (U/L) | Pre- treatment | 75.58 ± 6.61 | 75.82 ± 5.16 | 77.92 ± 5.10 | 0.220 |
Post treatment | 43.01 ± 2.41 | 33.95 ± 0.87 | 45.32 ± 1.55 | ||
Δ | -32.57 ± 28.86 | -41.87 ± 25.43 | -32.6 ± 26.26 | 0.308 | |
AST (U/L) | Pre- treatment | 76.93 ± 2.36 | 76.60 ± 2.85 | 78.17 ± 3.52 | 0.100 |
Post treatment | 45.86 ± 1.46 | 41.04 ± 0.97 | 43.07 ± 1.44 | ||
Δ | -31.07 ± 11.31 | -35.56 ± 14.85 | -35.1 ± 18.66 | 0.458 | |
GGT (U/L) | Pre- treatment | 88.10 ± 3.75 | 86.20 ± 4.72 | 87.20 ± 3.37 | 0.190 |
Post treatment | 55.00 ± 1.08 | 48.51 ± 1.66 | 48.86 ± 1.87 | ||
Δ | -33.10 ± 18.19 | -37.69 ± 18.71 | -38.34 ± 14.91 | 0.447 | |
FPG (mmol/L) | Pre- treatment | 5.88 ± 0.18 | 5.95 ± 0.15 | 5.86 ± 0.12 | 0.060 |
Post treatment | 5.70 ± 0.13 | 5.55 ± 0.13 | 5.58 ± 0.10 | ||
Δ | -0.18 ± 0.65 | -0.40 ± 0.61 | -0.28 ± 0.83 | 0.482 | |
B-ultrasonography | Cure | 8 (26.7%) | 10 (33.3%) | 12 (40.0%) | 0.549 |
Obviously effective | 11 (36.6%) | 7 (23.4%) | 6 (20.0%) | 0.303 | |
Effective | 9 (30.0%) | 10 (33.3%) | 10 (33.3%) | 0.950 | |
Non-effective | 2 (6.7%) | 3 (10.0%) | 2 (6.7%) | 0.857 | |
Effective rate | 93.3% | 90.0% | 93.3% | 0.857 | |
TCM symptom and signs score | Pre- treatment | 14.07 ± 0.45 | 14.10 ± 0.44 | 14.20 ± 0.46 | 0.506 |
Post treatment | 2.33 ± 0.26 a | 2.13 ± 0.32 b | 2.86 ± 0.27 c | < 0.001 | |
Δ | -11.74 ± 0.19 a | -11.97 ± 0.12 b | -11.34 ± 0.19 c | < 0.001 |